Brief: Strides Pharma Science Says Unit Receives USFDA Approval For Sevelamer Carbonate Tablets, 800 Mg
10/05/2024 07:55
May 10 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* STRIDES PHARMA SCIENCE LTD - STRIDES RECEIVES USFDA
APPROVAL
FOR SEVELAMER CARBONATE TABLETS, 800 MG
Source text for Eikon: ID:
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees